Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -143,770 | -69,436 | -169,451 | -120,210 | -43,832 |
| Depreciation Amortization | N/A | N/A | 0 | 145 | 0 |
| Accounts payable and accrued liabilities | 146 | -1,952 | N/A | 8,953 | N/A |
| Other Working Capital | -3,725 | -742 | 22,491 | 7,168 | 1,243 |
| Other Operating Activity | 19,961 | 12,990 | 10,317 | 13,715 | 2,101 |
| Operating Cash Flow | $-127,388 | $-59,140 | $-136,643 | $-90,229 | $-40,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -510 | -427 | -2,178 | -1,437 | -464 |
| Other Investing Activity | -2,500 | -2,000 | -18,858 | -16,000 | 0 |
| Investing Cash Flow | $-3,010 | $-2,427 | $-21,036 | $-17,437 | $-464 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,000 | N/A |
| Debt Issued | 19,966 | 179 | N/A | 36,568 | N/A |
| Debt Repayment | N/A | N/A | N/A | -656 | N/A |
| Common Stock Issued | 538 | 103 | N/A | 132,032 | N/A |
| Dividend Paid | -997 | -997 | 0 | N/A | -1,151 |
| Other Financing Activity | -31,127 | -936 | 501,548 | 58,430 | 114,134 |
| Financing Cash Flow | $-11,620 | $-1,651 | $501,548 | $227,374 | $112,983 |
| Beginning Cash Position | 436,245 | 436,245 | 92,376 | 92,376 | 20,345 |
| End Cash Position | 294,227 | 373,027 | 436,245 | 212,084 | 92,376 |
| Net Cash Flow | $-142,018 | $-63,218 | $343,869 | $119,708 | $72,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,388 | -59,140 | -136,643 | -90,229 | -40,488 |
| Capital Expenditure | -510 | -427 | N/A | -1,437 | N/A |
| Free Cash Flow | -127,898 | -59,567 | -136,643 | -91,666 | -40,488 |